Twist Bioscience Corporation (TWST) /
The cash flow of Twist Bioscience Corporation over the past 9 years
Chart Twist Bioscience Corporation: operating cash flow, capital expenditures, free cash flow, fiscal 2017–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Twist Bioscience Corporation's operating cash flow was -$47.63M and its capital expenditures $28M, leaving free cash flow of -$75.63M. Free cash flow was below zero in all 9 years shown. It ranged from -$226.24M in fiscal 2022 to -$57.9M in fiscal 2017. Capital expenditures were highest in fiscal 2022, at $101.86M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Sep 30, 2025 | -$47.63M | $28M | -$75.63M |
| 2024ended Sep 30, 2024 | -$64.09M | $5.08M | -$69.17M |
| 2023ended Sep 30, 2023 | -$142.47M | $27.78M | -$170.25M |
| 2022ended Sep 30, 2022 | -$124.39M | $101.86M | -$226.24M |
| 2021ended Sep 30, 2021 | -$112.24M | $27.06M | -$139.31M |
| 2020ended Sep 30, 2020 | -$142.25M | $9.87M | -$152.12M |
| 2019ended Sep 30, 2019 | -$87.94M | $14.76M | -$102.69M |
| 2018ended Sep 30, 2018 | -$66.16M | $3.69M | -$69.85M |
| 2017ended Sep 30, 2017 | -$51.3M | $6.59M | -$57.9M |
Fiscal years as Twist Bioscience Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Twist Bioscience Corporation
- The revenue of Twist Bioscience Corporation
- The profitability of Twist Bioscience Corporation
- The debt of Twist Bioscience Corporation
- All of Twist Bioscience Corporation's financials, charted
Companies of a similar size
- HQYHEALTHEQUITY, INC.
- PCVXVaxcyte, Inc.
- FLSFLOWSERVE CORP
- ZETAZeta Global Holdings Corp.
- BRKRBRUKER CORPORATION
Not investment advice. This page shows what Twist Bioscience Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.